CNS progression occurred in @ of @ ( @ % ) and @ of @ ( @ % ) patients without CNS metastases at baseline in the T-DM@ and XL arms , respectively , and in @ of @ ( @ % ) and @ of @ ( @ % ) patients with CNS metastases at baseline .